DENVER, Jan. 9, 2023
/PRNewswire/ -- Palantir Technologies Inc. ("Palantir," NYSE:
PLTR), a leading builder of operating systems for organizations
across the healthcare sector, today announced the launch of a
fit-for-purpose Quality Management System to help its life sciences
customers using the Foundry platform meet GxP requirements.
With this new offering, Palantir is now positioned to help life
sciences customers with their most critical workflows, including
end-to-end analysis of clinical data. A top-5 global pharmaceutical
company classified an instance of Palantir Foundry as GxP qualified
late last year, showcasing Foundry's ability to provide a single,
integrated platform to help accelerate the timeline to therapeutic
launch, from translation research through GxP-validated primary
submission, secondary analysis, and real-world
studies. Several additional major pharmaceutical
and contract research organizations are currently using
Palantir's QMS for platform certification.
Palantir Foundry is designed to help transform the way
organizations operate by creating a central operating system for
their data, leading to better data-driven decision making. With
Palantir's GxP qualification package, life sciences customers
can now take advantage of the same power and flexibility of Foundry
while maintaining compliance to 21 CFR Part 11
regulations.
"The launch of Foundry into the GxP-regulated space marks
a new chapter for Palantir's work in Life Sciences and is in line
with our commitment to provide the most comprehensive cutting-edge
software to our customers," said Palantir Chief Operating Officer
Shyam Sankar. "We intend to continue
to launch more purpose-built products in the healthcare space to
further accelerate our clients' transition to integrated clinical
data repositories and statistical computing environments."
Palantir continues to work with organizations in the healthcare
sector across the value chain and of all sizes. Its software is
currently deployed in all areas of the industry including in public
health, pharmaceuticals, biotech, clinical research, and healthcare
operations, to help power better decisions to the world's most
difficult problems.
Learn more about Palantir's work in health and life
sciences here.
About Palantir Technologies Inc.
Foundational software of tomorrow. Delivered today. Additional
information is available at https://www.palantir.com.
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
These statements may relate to, but are not limited to, Palantir's
expectations regarding the expected benefits of our software
platforms and offerings. Forward-looking statements are inherently
subject to risks and uncertainties, some of which cannot be
predicted or quantified. Forward-looking statements are based on
information available at the time those statements are made and
were based on current expectations as well as the beliefs and
assumptions of management as of that time with respect to future
events. These statements are subject to risks and uncertainties,
many of which involve factors or circumstances that are beyond our
control. These risks and uncertainties include our ability to meet
the unique needs of our customers; the failure of our platforms to
satisfy our customers or perform as desired; the frequency or
severity of any software and implementation errors; our platforms'
reliability; and our customers' ability to modify or terminate
their contracts. Additional information regarding these and other
risks and uncertainties is included in the filings we make with the
Securities and Exchange Commission from time to time. Except as
required by law, we do not undertake any obligation to publicly
update or revise any forward-looking statement, whether as a result
of new information, future developments, or otherwise.
Media Contact:
Lisa
Gordon
media@palantir.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/palantir-introduces-quality-management-system-for-life-sciences-301715969.html
SOURCE PALANTIR TECHNOLOGIES INC.